Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meridian Bioscience, Inc. Lowers FY 2012 Guidance


Thursday, 26 Jul 2012 07:15am EDT 

Meridian Bioscience, Inc. announced that for fiscal 2012, it expects net sales to be in the range of $171-$175 million and per share diluted earnings to be between $0.78-$0.81. Previous guidance called for net sales to be between $183-$192 million and per share diluted earnings to be between $0.85-$0.89. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $182 million and EPS of $0.85 for fiscal 2012. 

Company Quote

20.58
0.21 +1.03%
11 Jul 2014